PNEUMOCOCCAL DISEASE
Clinical trials for PNEUMOCOCCAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL DISEASE trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pfizer tests Next-Gen shot to protect babies from pneumococcal germs
⭐️ VACCINE ⭐️ OngoingThis study is testing a new pneumococcal vaccine (called PG4) in healthy 2-month-old infants to see if it is safe and how well it helps the body build protection compared to currently available vaccines. Researchers will give four shots over about 1.5 years and check for side eff…
Matched conditions: PNEUMOCOCCAL DISEASE
Phase: PHASE2 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 01, 2026 14:42 UTC
-
Pfizer tests new Super-Vaccine against pneumonia in chinese babies and adults
⭐️ VACCINE ⭐️ OngoingThis study is testing the safety of a new 20-strain pneumococcal vaccine (20vPnC) in healthy Chinese people of all ages, from infants to adults. The main goal is to see how well people tolerate the vaccine and to check for any side effects. Researchers will also measure the immun…
Matched conditions: PNEUMOCOCCAL DISEASE
Phase: PHASE1 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:34 UTC
-
Pfizer tracks infant safety for new pneumonia vaccine
⭐️ VACCINE ⭐️ OngoingThis study is monitoring the safety of the Prevenar 20 vaccine in real-world use in Japan. It is enrolling about 1,100 infants aged 2 to 6 months who are getting this vaccine for the first time. Researchers will track any side effects the infants experience after each of their fo…
Matched conditions: PNEUMOCOCCAL DISEASE
Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 23, 2026 15:15 UTC
-
Pfizer tests Next-Gen shot against Pneumonia-Causing bacteria
⭐️ VACCINE ⭐️ OngoingThis study is testing a new vaccine designed to protect adults from pneumococcal diseases like pneumonia and meningitis. It will involve 558 adults in different age groups to see how safe the vaccine is and how well it triggers an immune response. Participants will receive a sing…
Matched conditions: PNEUMOCOCCAL DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 04, 2026 15:30 UTC